Nivolumab as Maintenance Therapy Following Platinum-Based Chemotherapy in EGFR-mutant Lung Cancer Patients After TKI Failure

被引：0
|
作者：
Kim, J. [1 ,2 ]
Choi, C. -M. [1 ]
Lee, J. C. [1 ]
Ji, W. [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Kyung Hee Univ, Med Ctr, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Nivolulmab; EGFR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.02
引用
收藏
页码：S615 / S615
页数：1
相关论文
共 50 条
  • [41] Activation of AURKA contributes to TKI resistance in EGFR-mutant non-small lung cancer
    Lee, Meng-Hsuan
    Hong, Shiao-Ya
    Kao, Yu-Rung
    Wu, Cheng-Wen
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma
    Lee, Po-Hsin
    Huang, Yen-Hsiang
    Lin, Ho
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Tseng, Jeng-Sen
    Chang, Gee-Chen
    Yang, Tsung-Ying
    MEDICINA-LITHUANIA, 2022, 58 (07):
  • [43] Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
    Lee, Jong Seok
    Lee, Ki Hyeong
    Cho, Eun Kyung
    Kim, Dong-Wan
    Kim, Sang-We
    Kim, Joo-Hang
    Cho, Byoung Chul
    Kang, Jin Hyoung
    Han, Ji-Youn
    Min, Young Joo
    Park, Keunchil
    LUNG CANCER, 2018, 122 : 234 - 242
  • [44] Optimizing the Sequence of Anti-EGFR-Targeted Therapy in EGFR-Mutant Lung Cancer
    Meador, Catherine B.
    Jin, Hailing
    de Stanchina, Elisa
    Nebhan, Caroline A.
    Pirazzoli, Valentina
    Wang, Lu
    Lu, Pengcheng
    Vuong, Huy
    Hutchinson, Katherine E.
    Jia, Peilin
    Chen, Xi
    Eisenberg, Rosana
    Ladanyi, Marc
    Politi, Katerina
    Zhao, Zhongming
    Lovly, Christine M.
    Cross, Darren A. E.
    Pao, William
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 542 - 552
  • [45] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [46] Combination therapy with paclitaxel and gemcitabine after platinum-based chemotherapy in patients with advanced urothelial cancer
    Harada, Mirii
    Tomisaki, Ikko
    Minato, Akinori
    Onishi, Rei
    Terado, Michikazu
    Inatomi, Hisato
    Fujimoto, Naohiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 970 - 974
  • [47] Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Oxnard, G. R.
    Janjigian, Y. Y.
    Arcila, M. E.
    Kris, M. G.
    Ladanyi, M.
    Azzoli, C. G.
    Miller, V. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy
    Lu, MJ
    Sorich, J
    Hazarika, M
    Kim, M
    Del Priore, G
    Jacobs, AJ
    Chiang, C
    Liu, PC
    Fusco, E
    Curtin, JP
    Muggia, FM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (04) : 969 - +
  • [49] Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion
    Lee, Sang-Hyun
    Kim, Kyuhwan
    Lee, Eunyoung
    Lee, Kyungmin
    Ahn, Kyeong Hwan
    Park, Hansom
    Kim, Yelim
    Shin, Soeun
    Jeon, Sang Youl
    Hwang, Yongki
    Ahn, Dong Hyuck
    Kwon, Yong-Jun
    Moon, Seok Whan
    Moon, Mi Hyoung
    Kim, Kyung Soo
    Hyun, Kwanyong
    Kim, Tae-Jung
    Sung, Yeoun Eun
    Choi, Joon Young
    Park, Chan Kwon
    Kim, Sung Won
    Yeo, Chang Dong
    Sohn, Hyun-Jung
    Hyun, You-Seok
    Kim, Tai-Gyu
    Ku, Bosung
    Lim, Jeong Uk
    Kim, Seung Joon
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [50] Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES SCLC)
    Schneider, B. J.
    Gadgeel, S. M.
    Ramnath, N.
    Wozniak, A. J.
    Dy, G. K.
    Daignault, S.
    Kalemkerian, G. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345